申请人:MERCK SHARP & DOHME CORP.
公开号:US20170275260A1
公开(公告)日:2017-09-28
The present disclosure relates to compounds of formula I that are useful as modulators of α7 nAChR, compositions comprising such compounds, and the use of such compounds for preventing, treating, or ameliorating disease, particularly disorders of the central nervous system such as cognitive impairments in Alzheimer's disease, Parkinson's disease, and schizophrenia, as well as for L-DOPA induced-dyskinesia and inflammation
本公开涉及公式I的化合物,这些化合物可用作α7 nAChR的调节剂,包含这些化合物的组合物,以及利用这些化合物预防、治疗或改善疾病,特别是中枢神经系统疾病,如阿尔茨海默病、帕金森病和精神分裂症,以及L-多巴引起的运动障碍和炎症。